Insights

Benchmark International facilita con éxito la transacción entre Molzym GmbH & Co. KG y Bruker Daltronics GmbH & Co. KG

November 19, 2025

Benchmark International se complace en anunciar la adquisición del 100% de Molzym GmbH & Co. KG por Bruker Daltronics GmbH & Co. KG.

Molzym GmbH & Ko. KG, con sede en Bremen, Alemania, es una empresa líder en investigación biológica y diagnóstico de agentes infecciosos, centrada en el desarrollo de nuevos métodos y productos para la detección molecular de enfermedades infecciosas causadas por bacterias y hongos. Fundada por el Prof. Lorenz, la empresa vende actualmente sus kits y reactivos en más de 30 países y emplea a un equipo de 26 personas.

Bruker Daltronics GmbH & Co. KG, con sede en Bremen (Alemania), emplea a más de 9.700 personas en todo el mundo y suministra instrumentos científicos de alto rendimiento y soluciones analíticas y de diagnóstico para la investigación de procesos biológicos y químicos a nivel molecular, celular y microscópico.

Con la adquisición de Molzym, Bruker pretende reforzar su presencia en la investigación biológica y el diagnóstico de enfermedades infecciosas. Se espera que la experiencia, la tecnología y la buena reputación ayuden a Bruker a seguir creciendo.

Asegúrese el mejor acuerdo para su empresa - Póngase en contacto hoy mismo.

"Estamos muy satisfechos con esta exitosa transacción. Con Bruker hemos ganado un socio fuerte y experimentado. También nos gustaría expresar nuestro más sincero agradecimiento a todos los implicados por su apoyo durante el proceso." - Dr. Michael Lustig, Director General de Molzym GmbH & Ko. KG

Benchmark International desempeñó un papel clave en la gestión del proceso de transacción, desde la oferta inicial hasta la finalización. El equipo guió con éxito al cliente a lo largo de todo el proceso, incluyendo una exhaustiva due diligence, asegurando una estructura equilibrada que se alineaba con los objetivos estratégicos de ambas partes.

"Estamos orgullosos de haber apoyado a los accionistas de Molzym para asegurar esta adquisición estratégica por parte de Bruker. Esta asociación combina dos innovadores biotecnológicos muy respetados y posiciona a ambas compañías para un avance continuo en el diagnóstico molecular y las ciencias de la vida." - Malte Bockholt, Director de Transacciones, Benchmark International

Programar una llamada

Americas: Sam Smoot at +1 (813) 898 2350 / [email protected]

Europe: Michael Lawrie at +44 (0) 161 359 4400 / [email protected]

Africa: Anthony McCardle at +27 21 300 2055 / [email protected] 

 

ABOUT BENCHMARK INTERNATIONAL:

Benchmark International is a global M&A firm that provides business owners with creative, value-maximizing solutions for growing and exiting their businesses. Benchmark International has handled transactions across various industries from offices across the world. With decades of M&A experience, Benchmark International’s transaction teams have assisted business owners with achieving their objectives and ensuring the continued growth of their businesses. The firm has also been named the Investment Banking Firm of the Year by The M&A Advisor and the Global M&A Network, as well as the #1 Sell-side Privately Owned M&A Advisor in the World by PitchBook’s and LSEG's Global League Tables.

The content provided by Benchmark International, including articles, blog posts, videos, and other media, is for general informational purposes only and does not constitute legal, financial, investment, or business advice. While we strive for accuracy, the information may be based on third-party sources, market trends, and evolving industry data that are not independently verified or guaranteed to be current or complete. Any opinions expressed are those of the authors and do not necessarily reflect the views of Benchmark International. Market trends, forecasts, and forward-looking statements are inherently uncertain and subject to change. Nothing in our content should be relied upon as a substitute for personalized advice from qualified professionals. Benchmark International disclaims all liability for any loss or damage resulting from reliance on this content. Always consult with appropriate experts before making business decisions.

Share This Post
Categories

Get These Insights Delivered Directly To Your Email

Explore our curated collection today and stay ahead of the curve in M&A.

Related Posts
How to Attract the Right Buyers: What Makes a Business More ValuableIn the dynamic world of mergers and acquisitions (M&A), selling your business is a complex process that requires strategic planning, valuation expertise, and an understanding of what potential buyers are looking for. Buyers and investors are driven by various motives, including growth acceleration, market expansion, and portfolio diversification. Successfully attracting the right buyers can significantly impact the sale price and the overall success of the transaction. But what exactly can make your business more valuable and appealing to prospective buyers? Let’s explore the key factors that may enhance your company's attractiveness in M&A and how you can position your business for maximum appeal.Why Multi-Party Sale Processes Are an Opportunity for BuyersTo many acquirers, the words “competitive process” still carry an undertone of friction. They suggest distraction, inflated expectations, unnecessary pressure, and the risk of being used as a price tension rather than a serious counterparty. Yet this interpretation often misses the deeper reality. For most business owners, particularly founders and long-tenured operators, a multi-party sale process is not an act of aggression; it is an act of responsibility – to themselves, to the business, and to the buyer.
Not Finding What You're Looking For?
Ready to dive into our featured M&A content and gain valuable insights for your business?